|
Index of reports
> Death (48)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mozobil (Plerixafor Subcutaneous) death. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 48 Next >>
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 25.0 kg (55.0 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Thymoglobulin
Dosage: 229.9 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Thymoglobulin
Dosage: 254 mg, qd
Start date: 2012-06-16
End date: 2012-06-19
Clolar
Dosage: 70 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Other drugs received by patient: Busulfan; Thiotepa; Dilaudid; Meropenem; Cytarabine; Melphalan Hydrochloride; Fentanyl Citrate
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 108.0 kg (237.6 pounds)
Reactions: Blood Alkaline Phosphatase Increased, Bronchopulmonary Aspergillosis, Haemoptysis, Tinea Cruris, Haemorrhage Intracranial, Transfusion Reaction, Constipation, Mucosal Inflammation, Oesophageal Candidiasis, Respiratory Failure, Diarrhoea, Oral Candidiasis, Sepsis, Blood Creatinine Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: 560 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-19
End date: 2012-02-24
Mitoxantrone
Dosage: 8 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Etoposide
Dosage: 100 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Cytarabine
Dosage: 1000 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Other drugs received by patient: Omeprazole; Oxycontin; Neupogen; Multi-Vitamin; Biotene; Oxycodone HCL; Platelets; Acyclovir; Albuterol; Allopurinol; Carvedilol; Hydroxyurea; Docusate; Spiriva; Bactrim
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-21
Patient: female, weighing 25.0 kg (55.0 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Hypertension, Fusarium Infection
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Clolar
Dosage: 70 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Thymoglobulin
Dosage: 254 mg, qd
Start date: 2012-06-16
End date: 2012-06-19
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Thymoglobulin
Dosage: 229.9 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Other drugs received by patient: Meropenem; Fentanyl Citrate; Cytarabine; Thiotepa; Melphalan Hydrochloride; Dilaudid; Busulfan
Possible Mozobil side effects in male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-17
Patient: male, weighing 72.6 kg (159.7 pounds)
Reactions: Acute Myeloid Leukaemia, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Dosage: 17.4 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-30
End date: 2012-01-30
Mozobil
Dosage: 17.4 mg, qd
Start date: 2012-02-01
End date: 2012-02-04
Clofarabine
Dosage: 37 mg, qd
Start date: 2012-02-02
End date: 2012-02-05
Vancomycin
Dosage: 1 g, bid
Indication: Sepsis
Start date: 2012-02-05
End date: 2012-02-07
Clofarabine
Dosage: 37 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-30
End date: 2012-01-30
Other drugs received by patient: Daunorubicin HCL; Potassium Chloride; Nicotine; Fluticasone Propionate / Salmeterol; Acetaminophen and Codeine Phosphate; Ondansetron; Potassium Chloride; Allopurinol; Daunorubicin HCL; Cyclizine; Furosemide; Ipratropium Bromide; Chlordiazepoxide; Itraconazole; Acyclovir; Meropenem; Meropenem; Acetaminophen and Codeine Phosphate; Calcium Carbonate; Daunorubicin HCL
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-16
Patient: female, weighing 25.2 kg (55.4 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Cardiac Failure, Respiratory Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Thymoglobulin
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Thymoglobulin
Dosage: unk
Start date: 2012-06-16
End date: 2012-06-19
Other drugs received by patient: Melphalan Hydrochloride; Busulfan; Fentanyl; Thiotepa; Cytarabine; Dilaudid; Meropenem
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-08-13
Patient: female, weighing 25.2 kg (55.4 pounds)
Reactions: Ischaemia, Pulmonary Alveolar Haemorrhage, Pericardial Effusion, Renal Failure, Respiratory Failure, Cardiac Failure, Sepsis, Pleural Effusion, Fusarium Infection, Hypertension
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Mozobil
Dosage: 6 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-16
End date: 2012-06-18
Fludara
Dosage: 140 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-06-11
End date: 2012-06-15
Clolar
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-10
End date: 2012-01-11
Thymoglobulin
Dosage: unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-15
End date: 2012-01-18
Thymoglobulin
Dosage: unk
Start date: 2012-06-16
End date: 2012-06-19
Other drugs received by patient: Meropenem; Melphalan Hydrochloride; Cytarabine; Busulfan; Dilaudid; Fentanyl; Thiotepa
Possible Mozobil side effects in male
Reported by a physician from United States on 2012-08-07
Patient: male
Reactions: Cerebral Haemorrhage
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Dosage: unk
Indication: Haematopoietic Stem Cell Mobilisation
End date: 2012-07-25
Mozobil
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen
Possible Mozobil side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24
Patient: female, weighing 85.9 kg (189.0 pounds)
Reactions: White Blood Cell Count Decreased, Acute Myeloid Leukaemia, Pulmonary Alveolar Haemorrhage, Febrile Neutropenia, Lung Infection Pseudomonal, Pseudomonal Bacteraemia, Multi-Organ Failure, Respiratory Failure, Platelet Count Decreased, Cardiac Arrest, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Neupogen; Carvedilol; Cefpodoxime Proxetil; Polyethylene Glycol; Valacyclovir Hydrochloride; Furosemide; Fluconazole; Temazepam; Fluticasone W; Tramadol HCL; Lansoprazole; Nifedipine; Nifedipine; Docusate Sodium W; Ondansetron Hydrochloride; Potassium Chloride; Levothyroxine Sodium; Sorafenib; Heparin; Lisinopril
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-07-16
Patient: female, weighing 108.8 kg (239.4 pounds)
Reactions: Bronchopulmonary Aspergillosis, Haemoptysis, Haemorrhage Intracranial, Transfusion Reaction, Genital Rash, Mucosal Inflammation, Diarrhoea, Respiratory Failure, Sepsis, Liver Function Test Abnormal
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1000 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Etoposide
Dosage: 100 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Mozobil
Dosage: 560 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-19
End date: 2012-02-24
Mitoxantrone
Dosage: 8 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Other drugs received by patient: Allopurinol; Platelets; Biotene; Carvedilol; Docusate; Hydroxyurea; Neupogen; Acyclovir; Oxycodone HCL; Oxycontin; Bactrim; Albuterol; Omeprazole; Spiriva; Multi-Vitamin
Possible Mozobil side effects in 74 year old female
Reported by a physician from United States on 2012-07-11
Patient: 74 year old female, weighing 67.6 kg (148.7 pounds)
Reactions: Atelectasis, Hyperglycaemia, Hypotension, General Physical Health Deterioration, Hypercalcaemia, Ascites, Diarrhoea, Decubitus Ulcer, Urinary Tract Infection Bacterial, Dehydration, Hypomagnesaemia, Pleural Effusion, Splenic Haemorrhage, Diffuse Large B-Cell Lymphoma, Thrombocytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: 22840 mcg, qd
Start date: 2012-01-31
End date: 2012-02-01
Mozobil
Dosage: 22840 mcg, qd
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-01-30
End date: 2012-01-30
Mozobil
Dosage: 13704 mcg, once
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2012-01-25
End date: 2012-01-25
Filgrastim
Dosage: 570 mcg, qd
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2012-01-25
End date: 2012-02-01
Other drugs received by patient: Vitamin D; Heparin Lock-Flush; Magic Mouthwash; HP Supplement; Miralax; Steroid Therapy; Fluorodeoxyglucose F 18; Oxycodone HCL; Oxycodone HCL; Acetaminophen; Furosemide; Calcium Citrate; Potassium Chloride; Colace
Possible Mozobil side effects in male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-29
Patient: male, weighing 72.6 kg (159.7 pounds)
Reactions: Acute Myeloid Leukaemia, Renal Failure Acute
Adverse event resulted in: death
Drug(s) suspected as cause:
Vancomycin
Dosage: 1 g, bid
Indication: Sepsis
Start date: 2012-02-05
End date: 2012-02-07
Mozobil
Dosage: 17.4 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-30
End date: 2012-01-30
Mozobil
Dosage: 17.4 mg, qd
Start date: 2012-02-01
End date: 2012-02-04
Clofarabine
Dosage: 37 mg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-01-30
End date: 2012-01-30
Clofarabine
Dosage: 37 mg, qd
Start date: 2012-02-02
End date: 2012-02-05
Other drugs received by patient: Itraconazole; Meropenem; Meropenem; Ondansetron; Cyclizine; Daunorubicin HCL; Fluticasone Propionate / Salmeterol; Daunorubicin HCL; Acyclovir; Potassium Chloride; Allopurinol; Calcium Carbonate; Furosemide; Ipratropium Bromide; Nicotine; Acetaminophen and Codeine Phosphate; Potassium Chloride; Daunorubicin HCL; Acetaminophen and Codeine Phosphate; Chlordiazepoxide
Possible Mozobil side effects in 65 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient: 65 year old male
Reactions: Arrhythmia Supraventricular, Blood Pressure Systolic Decreased, Dyspnoea, Hypothermia, Hyperkalaemia, Anaemia, Ascites, Chronic Lymphocytic Leukaemia, Pleural Effusion, Thrombocytopenia, Asthenia, White Blood Cell Count Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Acyclovir; Pantoprazole; Simvastatin; Prochlorperazine; Tamsulosin HCL; Lenalidomide; Hydrocodone W; Temazepam; Trimethoprim + Sulfamethoxazole
Possible Mozobil side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14
Patient: male
Reactions: Pneumonia, Restlessness, Nausea, Platelet Count Decreased, Neutrophil Count Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Mitoxantrone; Etoposide; Granulocyte Colony Stimulating Factor; Cytarabine
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-06-01
Patient: female, weighing 73.8 kg (162.4 pounds)
Reactions: Death, Therapeutic Response Decreased, Upper Respiratory Tract Infection, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-01-13
End date: 2011-01-13
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-01-16
End date: 2011-01-16
Bortezomib
Dosage: 1.3 mg/m2, once
Indication: Multiple Myeloma
Start date: 2011-01-06
End date: 2011-01-06
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-02-06
End date: 2011-02-06
Mozobil
Dosage: 320 mcg/kg, once
Indication: Multiple Myeloma
Start date: 2011-01-09
End date: 2011-01-09
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-09
End date: 2011-01-09
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-13
End date: 2011-01-13
Mozobil
Dosage: 320 mcg/kg, qd
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2011-01-04
End date: 2011-01-06
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-16
End date: 2011-01-16
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-02-06
End date: 2011-02-06
Other drugs received by patient: Advair Diskus 100 / 50; Norvasc; Albuterol; Zithromax
Possible Mozobil side effects in
Reported by a physician from Germany on 2012-05-25
Patient:
Reactions: Sudden Cardiac Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Dosage: 0.24 mg/kg, once
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2012-01-31
End date: 2012-01-31
Mozobil
Indication: Multiple Myeloma
Other drugs received by patient: Chemotherapeutics NOS
Possible Mozobil side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-22
Patient: female, weighing 52.6 kg (115.7 pounds)
Reactions: Respiratory Disorder, Systemic Mycosis, Acute Leukaemia, Coagulopathy, Osteomyelitis, Pericardial Effusion, Adenovirus Infection, Colitis, Cytomegalovirus Infection, Bone Marrow Failure, Hypertension
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Cytarabine; Hydrocortisone; Vancomycin; Dapsone; Hydrocortisone; Alteplase; Cefazolin Sodium; Methotrexate; Acetaminophen; Cefepime; Nifedipine; Ondansetron; Magnesium Oxide; Phytonadione; Posaconazole; Potassium Chloride; Pantoprazole; Azithromycin; Calcium Carbonate; Lansoprazole; Etoposide; Diphenhydramine HCL; Enalapril Maleate; Dextrose W; Dextrose; Morphine Sulfate; Potassium Chloride; Vancomycin; Hydroxypropyl Methylcellulose; Lidocaine; Lorazepam; Ranitidine; Captopril; Ciprofloxacin; Filgrastim; Magnesium Sulfate; Sodium Chloride; Diphenhydramine HCL; Hydroxyzine; Lactated Ringer's; Nystatin; Solutions FOR Parenteral Nutrition
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-05-11
Patient: female, weighing 73.8 kg (162.4 pounds)
Reactions: Death, Therapeutic Response Decreased, Upper Respiratory Tract Infection, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-02-06
End date: 2011-02-06
Bortezomib
Dosage: 1.3 mg/m2, once
Indication: Multiple Myeloma
Start date: 2011-01-06
End date: 2011-01-06
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-02-06
End date: 2011-02-06
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-13
End date: 2011-01-13
Mozobil
Dosage: 320 mcg/kg, qd
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2011-01-04
End date: 2011-01-06
Mozobil
Dosage: 320 mcg/kg, once
Indication: Multiple Myeloma
Start date: 2011-01-09
End date: 2011-01-09
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-01-16
End date: 2011-01-16
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-16
End date: 2011-01-16
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-01-13
End date: 2011-01-13
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-09
End date: 2011-01-09
Other drugs received by patient: Albuterol; Norvasc; Zithromax; Advair Diskus 100 / 50
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-05-02
Patient: female, weighing 52.6 kg (115.7 pounds)
Reactions: Respiratory Disorder, Systemic Mycosis, Coagulopathy, Acute Leukaemia, Osteomyelitis, Pericardial Effusion, Adenovirus Infection, Cytomegalovirus Infection, Bone Marrow Failure, Colitis, Hypertension
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Ranitidine; Vancomycin; Hydroxypropyl Methylcellulose; Lactated Ringer's; Magnesium Sulfate; Diphenhydramine HCL; Hydroxyzine; Azithromycin; Posaconazole; Hydrocortisone; Pantoprazole; Alteplase; Calcium Carbonate; Cefazolin Sodium; Lansoprazole; Cytarabine; Dextrose W; Potassium Chloride; Sodium Chloride; Dapsone; Diphenhydramine HCL; Hydrocortisone; Nifedipine; Captopril; Solutions FOR Parenteral Nutrition; Etoposide; Enalapril Maleate; Lidocaine; Morphine Sulfate; Nystatin; Acetaminophen; Lorazepam; Vancomycin; Dextrose; Filgrastim; Phytonadione; Potassium Chloride; Cefepime; Ondansetron; Ciprofloxacin; Magnesium Oxide; Methotrexate
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-04-26
Patient: female, weighing 52.6 kg (115.7 pounds)
Reactions: Death, Systemic Mycosis, Adenovirus Infection, Osteomyelitis, Bone Marrow Failure
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Other drugs received by patient: Cefepime; Hydrocortisone; Lorazepam; Ranitidine; Etoposide; Dapsone; Pantoprazole; Acetaminophen; Cytarabine; Enalapril Maleate; Diphenhydramine HCL; Hydroxyzine; Nifedipine; Ondansetron; Vancomycin
Possible Mozobil side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-25
Patient:
Reactions: Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Indication: Haematopoietic Stem Cell Mobilisation
Mozobil
Indication: Multiple Myeloma
Possible Mozobil side effects in
Reported by a consumer/non-health professional from Germany on 2012-04-24
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Indication: Multiple Myeloma
Mozobil
Dosage: unk
Indication: Haematopoietic Stem Cell Mobilisation
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-04-19
Patient: female, weighing 73.8 kg (162.4 pounds)
Reactions: Death, Therapeutic Response Decreased, Upper Respiratory Tract Infection, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-02-06
End date: 2011-02-06
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-01-16
End date: 2011-01-16
Bortezomib
Dosage: 1.3 mg/m2, once
Indication: Multiple Myeloma
Start date: 2011-01-06
End date: 2011-01-06
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-16
End date: 2011-01-16
Mozobil
Dosage: 320 mcg/kg, once
Indication: Multiple Myeloma
Start date: 2011-01-09
End date: 2011-01-09
Mozobil
Dosage: 320 mcg/kg, once
Start date: 2011-01-13
End date: 2011-01-13
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-13
End date: 2011-01-13
Mozobil
Dosage: 320 mcg/kg, qd
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2011-01-04
End date: 2011-01-06
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-01-09
End date: 2011-01-09
Bortezomib
Dosage: 1.3 mg/m2, once
Start date: 2011-02-06
End date: 2011-02-06
Other drugs received by patient: Albuterol; Norvasc; Advair Diskus 100 / 50; Zithromax
Possible Mozobil side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-17
Patient: female, weighing 91.4 kg (201.1 pounds)
Reactions: Fluid Overload, Death, Lymphopenia, Opportunistic Infection, Febrile Neutropenia, Convulsion
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: 240 mcg/kg, qd
Start date: 2011-12-05
End date: 2011-12-05
Mozobil
Dosage: 240 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2011-11-23
End date: 2011-11-23
Other drugs received by patient: Neupogen; Phenergan HCL; Fexofenadine W; Sodium Chloride; Sorafenib; ABH; Dilaudid; Lomotil; Zofran; Valtrex; Hydralazine HCL; Hydromorphone HCL; Sodium Chloride; Sodium Chloride; Neupogen; Cytarabine; Protonix; Toprol-XL; Triamcinolone; Dextromethorphan W; Ondansetron; Oyster Shell Calcium; Silver Sulfadiazine; Sodium Chloride; Albuterol; Ambien; Phenergan HCL; Zofran; Diovan HCT; Heparin Lock-Flush; Synthroid; Triamcinolone; Camphor W; Magnesium Sulfate; Potassium Chloride; Docusate Sodium W; Tramadol HCL; White Petroleum; Hycodan; Protonix; Vantin; Fluocinonide; Hydrocodone W; Hydromorphone HCL; Insulin Lispro; Linezolid; ABH; Acetaminophen; Cefepime Hydrochloride; Diphenhydramine HCL; Granisetron; Throat Preparations; Potassium Chloride; Xanax; Diovan HCT; Lantus; Magnesium; Potassium; Dextrose; Hydroxyzine; Insulin Lispro; Ondansetron; Docusate Sodium W; Vitamin TAB; Sucralfate; Tramadol HCL; Sorafenib; Tessalon; Effexor XR; Novolog; Vfend; Acetaminophen; Aluminium W; Cefepime Hydrochloride; Hydrocodone W; Hydrocortisone Sodium Succinate; Hydromorphone HCL; Magnesium Sulfate; Metoclopramide; Sodium Chloride
Possible Mozobil side effects in female
Reported by a physician from United States on 2012-03-20
Patient: female, weighing 108.8 kg (239.4 pounds)
Reactions: Respiratory Failure, Sepsis, Haemorrhage Intracranial
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: 560 mcg/kg, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-19
End date: 2012-02-24
Mitoxantrone
Dosage: 8 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Etoposide
Dosage: 100 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Cytarabine
Dosage: 1000 mg/m2, qd
Indication: Acute Myeloid Leukaemia
Start date: 2012-02-20
End date: 2012-02-24
Other drugs received by patient: Platelets; Neupogen
Possible Mozobil side effects in 39 year old female
Reported by a pharmacist from South Africa on 2012-03-15
Patient: 39 year old female
Reactions: Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Mozobil
Dosage: 20 mg, qd
Indication: Haematopoietic Stem Cell Mobilisation
Mozobil
Indication: non-Hodgkin's Lymphoma
Possible Mozobil side effects in 74 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-09
Patient: 74 year old female, weighing 67.6 kg (148.7 pounds)
Reactions: Hypotension, Generalised Oedema, Splenic Infarction, Ascites, Death, Dehydration, Splenic Haemorrhage, Vascular Pseudoaneurysm, Splenomegaly, Splenic Rupture
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: 22840 mcg, qd
Start date: 2012-01-31
End date: 2012-02-01
Mozobil
Dosage: 22840 mcg, qd
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-01-30
End date: 2012-01-30
Mozobil
Dosage: 13704 mcg, once
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2012-01-25
End date: 2012-01-25
Filgrastim
Dosage: 570 mcg, qd
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2012-01-25
End date: 2012-02-01
Other drugs received by patient: Miralax; Steroid Therapy; Vitamin D; Oxycodone HCL; Oxycodone HCL; Fluorodeoxyglucose F 18; Calcium; Colace
Possible Mozobil side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-05
Patient: male, weighing 21.5 kg (47.3 pounds)
Reactions: Acute Lymphocytic Leukaemia, Adenovirus Infection, Cystitis Haemorrhagic, Acute Graft Versus Host Disease in Skin, Pleural Effusion, Pericardial Effusion, Ascites
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Indication: Acute Lymphocytic Leukaemia
Mozobil
Dosage: 5 mg, qd
Indication: Bone Marrow Conditioning Regimen
Start date: 2011-10-11
End date: 2011-10-12
Other drugs received by patient: Acyclovir; Micafungin; Zofran; Amlodipine; Cidofovir; Thiotepa; Dexamethasone; Fludara; Melphalan Hydrochloride; Levaquin
Possible Mozobil side effects in male
Reported by a physician from United States on 2012-03-02
Patient: male, weighing 80.1 kg (176.2 pounds)
Reactions: Productive Cough, Tachycardia, Clostridium Difficile Colitis, Pyrexia, Lactic Acidosis, Muscle Haemorrhage, Post-Traumatic Pain, Dyspepsia, Oedema Peripheral, Pulmonary Oedema, Hypoxia, Back Pain, Phlebitis, Pneumonia, Pain in Extremity, Hypoaesthesia, Delirium, Insomnia, Rash Erythematous, Streptococcal Bacteraemia, Chills, Mental Status Changes, Constipation, Generalised Oedema, Hepatomegaly, Pleural Effusion, Dizziness, Tachypnoea, Depression, Hallucination, Nausea, Acquired Diaphragmatic Eventration, Arthralgia, Respiratory Failure, Deep Vein Thrombosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Indication: Haematopoietic Stem Cell Mobilisation
Mozobil
Dosage: 46.6 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-09-02
End date: 2011-10-08
Other drugs received by patient: Acetaminophen; Loperamide HCL; Rosuvastatin; Isosorbide Mononitrate; Metoprolol Succinate; Lorazepam; Meropenem; Gastrografin; Acetaminophen; Phytonadione; Magnesium Sulfate; Magnesium Sulfate; Cefepime; Ranexa; Furosemide; Furosemide; Allopurinol; Metoprolol Succinate; Vancomycin; Hydromorphone HCL; Furosemide; Ramipril; Metoprolol Succinate; Digoxin; Metronidazole; Acetaminophen; Phytonadione; Magnesium Sulfate; Albuterol; Diphenhydramine HCL; Heparin Lock-Flush; Vancomycin; Hydromorphone HCL; Potassium Chloride; Potassium Chloride; Potassium Chloride; Acetylcysteine; Multi-Vitamin; Metronidazole; Ipratropium Bromide; Sodium Chloride; Hydrocortisone; Decitabine; Phytonadione; Ipratropium Bromide; Albuterol; Albuterol; Ranexa; Furosemide; Allopurinol; Isosorbide Mononitrate; Metoprolol Succinate; Voriconazole; Potassium Chloride; Piperacillin W; Acetaminophen; Furosemide; Lidocaine; Metoprolol Succinate; Diphenhydramine HCL; Vancomycin; Biotene; Metronidazole; Cefepime; Furosemide; Potassium Chloride; Potassium Chloride; Digoxin; Digoxin
Possible Mozobil side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-22
Patient: male, weighing 21.5 kg (47.3 pounds)
Reactions: Acute Lymphocytic Leukaemia, Cystitis Haemorrhagic, Acute Graft Versus Host Disease in Skin, Adenovirus Infection, Pleural Effusion, Pericardial Effusion, Ascites
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: 5 mg, qd
Indication: Bone Marrow Conditioning Regimen
Start date: 2011-10-11
End date: 2011-10-12
Mozobil
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Dexamethasone; Thiotepa; Fludara; Melphalan Hydrochloride; Acyclovir; Amlodipine; Levaquin; Cidofovir; Zofran; Micafungin
Possible Mozobil side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-17
Patient: male
Reactions: Acute Lymphocytic Leukaemia, Pleural Effusion, Ascites
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Mozobil
Dosage: 5 mg, qd
Indication: Bone Marrow Conditioning Regimen
Start date: 2011-10-11
End date: 2011-10-12
Mozobil
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Acyclovir; Cidofovir; Fludara; Thiotepa; Zofran; Melphalan Hydrochloride; Micafungin; Dexamethasone; Amlodipine; Levaquin
Page 1 Next >>
|
